Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126587211 | 12658721 | 1 | I | 20160803 | 20160817 | 20160817 | EXP | PL-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-122214 | RANBAXY | BERBEKA K, DEBSKA M. TOXOPLASMOSIS INFECTION DURING PREGNANCY - THE POOR PROGNOSIS FOR THE FETUS. POST N MED. 2016;XXIX (7):452-455 | 37.00 | YR | F | Y | 0.00000 | 20160817 | OT | PL | PL |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126587211 | 12658721 | 1 | SS | OMEPRAZOLE. | OMEPRAZOLE | 1 | Unknown | U | U | 0 | |||||||||
| 126587211 | 12658721 | 2 | PS | FOLIC ACID. | FOLIC ACID | 1 | Unknown | 10 MG, UNK | U | U | 40582 | 10 | MG | ||||||
| 126587211 | 12658721 | 3 | SS | Rovamycin | SPIRAMYCIN | 1 | Unknown | 9 MIN U, DAILY | N | U | 0 | ||||||||
| 126587211 | 12658721 | 4 | SS | Pyrimethamine | PYRIMETHAMINE | 1 | Oral | 50 MG, BID | N | U | 0 | 50 | MG | Q12H | |||||
| 126587211 | 12658721 | 5 | SS | SULFADIAZINE. | SULFADIAZINE | 1 | Oral | 2 G, BID | N | U | 0 | 2 | G | Q12H | |||||
| 126587211 | 12658721 | 6 | SS | Spiramycin | SPIRAMYCIN | 1 | Unknown | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126587211 | 12658721 | 1 | Prophylaxis |
| 126587211 | 12658721 | 2 | Product used for unknown indication |
| 126587211 | 12658721 | 3 | Toxoplasmosis |
| 126587211 | 12658721 | 4 | Toxoplasmosis |
| 126587211 | 12658721 | 5 | Toxoplasmosis |
| 126587211 | 12658721 | 6 | Toxoplasmosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126587211 | 12658721 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126587211 | 12658721 | Disease progression | |
| 126587211 | 12658721 | Drug resistance | |
| 126587211 | 12658721 | Exposure during pregnancy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |